Recent Finacing
Recent Raise
Pipeline Therapeutics is a clinical-stage biopharmaceutical company developing small-molecule therapeutics for neuroregeneration—synaptogenesis, remyelination, and axonal repair—with lead programs PIPE-505 (hearing loss) and PIPE-307 (MS).
